. . . . . . . "3.548E9"^^ . . . . . . . "Ky\u014Dwa Hakk\u014D Kirin K.K. (jap. \u5354\u548C\u767A\u9175\u30AD\u30EA\u30F3\u682A\u5F0F\u4F1A\u793E, ~ Kabushiki kaisha, engl. Kyowa Hakko Kirin Co., Ltd.) ist ein japanischer Pharmakonzern. Er entstand 2008 durch Zusammenschluss von Ky\u014Dwa Hakk\u014D K\u014Dgy\u014D K.K. (\u5354\u548C\u91B1\u9175\u5DE5\u696D\u682A\u5F0F\u4F1A\u793E) und Kirin Pharma K.K. (\u30AD\u30EA\u30F3\u30D5\u30A1\u30FC\u30DE\u682A\u5F0F\u4F1A\u793E). Ky\u014Dwa Hakk\u014D Kirin patentierte Hydrotalkit f\u00FCr medizinische Anwendungen (Talcid) und erfand das Fermentationsverfahren zur Mononatriumglutamat-Herstellung. Wichtige Arzneimittel sind z. B. Istradefyllin, Loracarbef und , einem monoklonalen Antik\u00F6rper zur Behandlung der Adulten T-Zell-Leuk\u00E4mie. Auch der Wachstumsregulator Forchlorfenuron wurde von Ky\u014Dwa Hakk\u014D entwickelt. Zu Ky\u014Dwa Hakk\u014D geh\u00F6ren die internationalen Tochterunternehmen KH Neochem und ProStrakan."@de . . . . . . . . "1949"^^ . "FWB:KY4"@en . . . . . ""@en . . . . . . . . "$ 3.548 billion USD"@en . . "Kyowa Kirin \u2014 \u044F\u043F\u043E\u043D\u0441\u043A\u0430\u044F \u0444\u0430\u0440\u043C\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043A\u0430\u044F \u043A\u043E\u043C\u043F\u0430\u043D\u0438\u044F, \u0434\u043E\u0447\u0435\u0440\u043D\u044F\u044F \u0441\u0442\u0440\u0443\u043A\u0442\u0443\u0440\u0430 \u043F\u0438\u0432\u043E\u0432\u0430\u0440\u0435\u043D\u043D\u043E\u0439 \u0433\u0440\u0443\u043F\u043F\u044B Kirin Holdings (\u0435\u0439 \u043F\u0440\u0438\u043D\u0430\u0434\u043B\u0435\u0436\u0438\u0442 53,4 % \u0430\u043A\u0446\u0438\u0439).."@ru . "Kyowa Kirin Co., Ltd. (\u5354\u548C\u30AD\u30EA\u30F3\u682A\u5F0F\u4F1A\u793E Ky\u014Dwa Kirin Kabushiki Kaisha) adalah perusahaan farmasi dan bioteknologi Jepang di bawah Kirin Holdings, dan termasuk di antara 40 pendapatan terbesar di dunia. Perusahaan ini berkantor pusat di Chiyoda-ku, Tokyo dan merupakan anggota indeks saham Nikkei 225."@in . "Kyowa Kirin"@in . . . . . . . . "Nobuo Hanai,"@en . . "Kyowa Kirin Co., Ltd. (\u5354\u548C\u30AD\u30EA\u30F3\u682A\u5F0F\u4F1A\u793E Ky\u014Dwa Kirin Kabushiki Kaisha) adalah perusahaan farmasi dan bioteknologi Jepang di bawah Kirin Holdings, dan termasuk di antara 40 pendapatan terbesar di dunia. Perusahaan ini berkantor pusat di Chiyoda-ku, Tokyo dan merupakan anggota indeks saham Nikkei 225."@in . . . "Kyowa Kirin \u2014 \u044F\u043F\u043E\u043D\u0441\u043A\u0430\u044F \u0444\u0430\u0440\u043C\u0430\u0446\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043A\u0430\u044F \u043A\u043E\u043C\u043F\u0430\u043D\u0438\u044F, \u0434\u043E\u0447\u0435\u0440\u043D\u044F\u044F \u0441\u0442\u0440\u0443\u043A\u0442\u0443\u0440\u0430 \u043F\u0438\u0432\u043E\u0432\u0430\u0440\u0435\u043D\u043D\u043E\u0439 \u0433\u0440\u0443\u043F\u043F\u044B Kirin Holdings (\u0435\u0439 \u043F\u0440\u0438\u043D\u0430\u0434\u043B\u0435\u0436\u0438\u0442 53,4 % \u0430\u043A\u0446\u0438\u0439).."@ru . . . "Kyowa Kirin"@en . "7532"^^ . . "Kyowa Kirin"@ru . "$ 31.32 million USD"@en . . . . . . . . . "1949-07-01"^^ . . . . . . "Kyowa Kirin Co., Ltd."@en . "Kyowa Hakko Kirin Logo.svg"@en . . . . . . . . . "7532"^^ . . . . . . . . "\u5354\u548C\u30AD\u30EA\u30F3\u682A\u5F0F\u4F1A\u793E\uFF08\u304D\u3087\u3046\u308F\u30AD\u30EA\u30F3\uFF09\u306F\u3001\u533B\u7642\u7528\u533B\u85AC\u54C1\u4E8B\u696D\u7B49\u3092\u884C\u3046\u3001\u88FD\u85AC\u4F01\u696D\u3067\u3042\u308B\u3002\u304B\u3064\u3066\u306F\u3001\u65E5\u672C\u9152\u30FB\u713C\u914E\u30FB\u30EF\u30A4\u30F3\u306E\u88FD\u9020\u3092\u624B\u639B\u3051\u308B\u9152\u9020\u30E1\u30FC\u30AB\u30FC\u3067\u3082\u3042\u3063\u305F\u3002\u30AD\u30EA\u30F3\u30DB\u30FC\u30EB\u30C7\u30A3\u30F3\u30B0\u30B9\u306E\u5B50\u4F1A\u793E\u3067\u3001\u30AD\u30EA\u30F3\u30B0\u30EB\u30FC\u30D7\u306B\u5C5E\u3059\u308B\u3002\u65E5\u7D4C\u5E73\u5747\u682A\u4FA1\u306E\u69CB\u6210\u9298\u67C4\u306E\u4E00\u3064\u3002"@ja . "47"^^ . "1949-07-01"^^ . . . "Ky\u014Dwa Hakk\u014D Kirin"@de . . "Kyowa Kirin Co., Ltd. (\u5354\u548C\u30AD\u30EA\u30F3\u682A\u5F0F\u4F1A\u793E, Ky\u014Dwa Kirin Kabushiki Kaisha) is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index."@en . . . . . . "3.4061E11"^^ . "27406017"^^ . "Kyowa Kirin Co., Ltd. (\u5354\u548C\u30AD\u30EA\u30F3\u682A\u5F0F\u4F1A\u793E, Ky\u014Dwa Kirin Kabushiki Kaisha) is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index."@en . . . . . . . "\u5354\u548C\u30AD\u30EA\u30F3\u682A\u5F0F\u4F1A\u793E\uFF08\u304D\u3087\u3046\u308F\u30AD\u30EA\u30F3\uFF09\u306F\u3001\u533B\u7642\u7528\u533B\u85AC\u54C1\u4E8B\u696D\u7B49\u3092\u884C\u3046\u3001\u88FD\u85AC\u4F01\u696D\u3067\u3042\u308B\u3002\u304B\u3064\u3066\u306F\u3001\u65E5\u672C\u9152\u30FB\u713C\u914E\u30FB\u30EF\u30A4\u30F3\u306E\u88FD\u9020\u3092\u624B\u639B\u3051\u308B\u9152\u9020\u30E1\u30FC\u30AB\u30FC\u3067\u3082\u3042\u3063\u305F\u3002\u30AD\u30EA\u30F3\u30DB\u30FC\u30EB\u30C7\u30A3\u30F3\u30B0\u30B9\u306E\u5B50\u4F1A\u793E\u3067\u3001\u30AD\u30EA\u30F3\u30B0\u30EB\u30FC\u30D7\u306B\u5C5E\u3059\u308B\u3002\u65E5\u7D4C\u5E73\u5747\u682A\u4FA1\u306E\u69CB\u6210\u9298\u67C4\u306E\u4E00\u3064\u3002"@ja . "1124571476"^^ . . "Kyowa Kirin Co., Ltd."@en . "6724"^^ . . . . . . . . . . . . ""@en . . . . "\u5354\u548C\u30AD\u30EA\u30F3"@ja . . "200"^^ . . . . . "Ky\u014Dwa Hakk\u014D Kirin K.K. (jap. \u5354\u548C\u767A\u9175\u30AD\u30EA\u30F3\u682A\u5F0F\u4F1A\u793E, ~ Kabushiki kaisha, engl. Kyowa Hakko Kirin Co., Ltd.) ist ein japanischer Pharmakonzern. Er entstand 2008 durch Zusammenschluss von Ky\u014Dwa Hakk\u014D K\u014Dgy\u014D K.K. (\u5354\u548C\u91B1\u9175\u5DE5\u696D\u682A\u5F0F\u4F1A\u793E) und Kirin Pharma K.K. (\u30AD\u30EA\u30F3\u30D5\u30A1\u30FC\u30DE\u682A\u5F0F\u4F1A\u793E). Zu Ky\u014Dwa Hakk\u014D geh\u00F6ren die internationalen Tochterunternehmen KH Neochem und ProStrakan."@de . . . . "Public"@en . . . . . . "Ohtemachi Building, 1-6-1, \u014Ctemachi, Chiyoda-ku, Tokyo 100-8185, Japan"@en .